Connor JR, Roskams AJ, Menzies SL, Williams ME. 1993. Transferrin in
the central nervous system of the shiverer mouse myelin mutant. J Neurosci
Res 36:501–507.
Cutler RG, Kelly J, Storie K, Pedersen WA, Tammara A, Hatanpaa K,
Troncoso JC, Mattson MP. 2004. Involvement of oxidative stressinduced abnormalities in ceramide and cholesterol metabolism in brain
aging and Alzheimer's disease. Proc Natl Acad Sci USA 101:2070–2075.
Gu Y, Misonou H, Sato T, Dohmae N, Takio K, Ihara Y. 2001. Distinct intramembrane cleavage of the b-amyloid precursor protein family re-sembling
gamma-secretase-like cleavage of Notch. J Biol Chem 276:35235–35238.
Hammad SM, Ranganathan S, Loukinova E, Twal WO, Argraves WS.
1997. Interaction of apolipoprotein J-amyloid beta-peptide complex with
low density lipoprotein receptor-related protein-2/megalin. A mechanism
to prevent pathological accumulation of amyloid beta-peptide. J Biol Chem
272:18644–18649.
Henkemeyer M, Marengere LE, McGlade J, Olivier JP, Conlon RA,
Holmyard DP, Letwin K, Pawson T. 1994. Immunolocalization of the
Nuk receptor tyrosine kinase suggests roles in segmental patterning of
the brain and axonogenesis. Oncogene 9:1001–1014.
Hja ̈lm G, Murray E, Crumley G, Harazim W, Lundgren S, Onyango I,
Ek B, Larsson M, Juhlin C, Hellman P, Davis H, A° kerstro ̈ m G, Rask L,
Morse B. 1996. Cloning and sequencing of human gp330, a Ca(2))- binding receptor with potential intracellular signaling properties. Eur
J Biochem 239:132–137.
Hoe HS, Rebeck GW. 2005. Regulation of ApoE receptor proteolysis by
ligand binding. Brain Res Mol Brain Res 137:31–39.
Juhlin C, Holmdahl R, Johansson H, Rastad J, A° kerstro ̈ m G, Klareskog L.
1987. Monoclonal antibodies with exclusive reactivity against parathyroid cells and tubule cells of the kidney. Proc Natl Acad Sci USA 84:
2990–2994.
Kanalas JJ, Makker SP. 1990. Isolation of a 330-kDa glycoprotein from
human kidney similar to the Heymann nephritis autoantigen (gp330).
J Am Soc Nephrol 1:792–798.
Kounnas MZ, Haudenschild CC, Strickland DK, Argraves WS. 1994.
Immunological localization of glycoprotein 330, low density lipoprotein
receptor related protein and 39 kDa receptor associated protein in
embryonic mouse tissues. In Vivo 8:343–351.
Larsson M, Hja ̈lm G, Sakwe AM, Engstro ̈ m A, Ho ̈ glund AS, Larsson E,
Robinson RC, Sundberg C, Rask L. 2003. Selective interaction of megalin with postsynaptic density-95 (PSD-95)-like membrane-associated
guanylate kinase (MAGUK) proteins. Biochem J 373:381–391.
Lendon CL, Ashall F, Goate AM. 1997. Exploring the etiology of Alzheimer disease using molecular genetics. JAMA 277:825–831.
Lo ̈ vblad K, Ramelli G, Remonda L, Nirkko AC, Ozdoba C, Schroth G.
1997. Retardation of myelination due to dietary vitamin B12 deficiency:
cranial MRI findings. Pediatr Radiol 27:155–158.
Lundgren S, Carling T, Hja ̈lm G, Juhlin C, Rastad J, Pihlgren U, Rask L,
A° kerstro G,
̈ m Hellman P. 1997. Tissue distribution of human gp330/
megalin, a putative Ca(2))-sensing protein. J Histochem Cytochem 45:
383–392.
